A multicenter, prospective cohort study of Tongqiao Biyan granule in the prevention and treatment of asthma allergic rhinitis in children based on the real medical environment and the Chi
- Conditions
- Children's asthma allergic rhinitis
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) having a history of asthma with allergic rhinitis, (2) being 3-13 years old (< 14 years old) , (3) having entered the Chinese childhood asthma action plan and using leisurely breathing APP, being in the Green Zone of asthma, (4) the symptoms of rhinitis (nasal obstruction, nasal discharge, sneezing, nasal itching) appeared recently (nearly 1 week) , or the symptoms of rhinitis aggravated to moderate-severe recently (nearly 1 week) ; (5) voluntary participation in the study and informed consent signed by the legal guardian or with the child (=8 years old) .
(1) having diseases that need to be differentiated from AR, such as upper and lower respiratory tract infection, acute rhinosinusitis, etc. ;
(2) having risk factors of fatal asthma attack;
(3) being allergic to Tongqiao Biyan granule and its components.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method